SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
May 10, 2016
Date of report (Date of earliest event reported)
____________________________________
BIOLIFE SOLUTIONS, INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 001-36362 | 94-3076866 |
| (State or Other Jurisdiction of Incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
3303 Monte Villa Parkway, Bothell, WA 98021
(Address of principal executive offices, including zip code)
(425) 402-1400
(Registrant’s telephone number, including area code)
____________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 10, 2016, BioLife Solutions, Inc. (the “Company”) held its 2016 Annual Meeting of Stockholders (the “Annual Meeting”) at its principal executive office in Bothell, Washington. At the Annual Meeting, the Company’s stockholders approved each of the following proposals set forth in the Company’s Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission on March 30, 2016:
Proposal 1: Election of Directors.
The Company’s stockholders elected the following directors to hold office until the 2017 Annual Meeting:
| Name | Votes For | Votes Withheld | Broker Non-Votes |
| Michael Rice | 6,787,518 | 104,301 | 2,873,323 |
| Raymond Cohen | 6,786,809 | 105,010 | 2,873,323 |
| Andrew Hinson | 6,868,036 | 23,783 | 2,873,323 |
| Joseph Schick | 6,868,039 | 23,780 | 2,873,323 |
| Rick Stewart | 6,868,046 | 23,773 | 2,873,323 |
| Thomas Girschweiler | 6,788,944 | 102,875 | 2,873,323 |
Proposal 2: Approval of Compensation of Named Executive Officers (Say on Pay).
The Company’s stockholders approved the non-binding advisory vote on the compensation of our named executive officers, as set forth below:
| Votes For | Votes Against | Abstain | Broker Non-Votes |
| 6,714,824 | 172,930 | 4,065 | 2,873,323 |
Proposal 3: Ratification of Auditors.
The Company’s stockholders ratified the appointment of Peterson Sullivan LLP as our independent registered public accounting firm for 2016, as set forth below:
| Votes For | Votes Against | Abstain |
| 9,556,180 | 54,078 | 154,884 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BIOLIFE SOLUTIONS, INC. | |||
| Dated: May 12, 2016 | By: | /s/ Roderick de Greef |
|
| Roderick de Greef | |||
| Chief Financial Officer and Secretary | |||